The cationic amphiphilic molecules as potential immunostimulants for HIV-1 infection.
Achour
A
A
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride